ExLibris header image
SFX Logo
Title: Resistance to the Novel Translation Inhibitor Silvestrol Is Mediated by Elevated Mcl-1 Expression.
Source:

Blood [0006-4971] Lucas, David yr:2009


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Bourdeau, A. "Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol." PloS one 4.4 (2009): 1-14. Link to Full Text for this item Link to SFX for this item
2. Alachkar, H. "Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.(Research)." Journal of Hematology & Oncology 6 (2013): 21-. Link to Full Text for this item Link to SFX for this item
3. Jin, C. "Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein." Oncogene 32.17 (2012): 2179-2188. Link to Full Text for this item Link to SFX for this item
4. Tsumuraya, T. "Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia." Biochemical pharmacology 81.6 (2011): 713-722. Link to SFX for this item
5. Chen, R. "Strategy to induce apoptosis and circumvent resistance in chronic lymphocytic leukaemia." Best Practice & Research Clinical Haematology 23.1 (2010): 155-166. Link to SFX for this item
6. Adams, E. "Total Synthesis of the Potent Anticancer Aglaia Metabolites (-)-Silvestrol and (-)-Episilvestrol and the Active Analogue (-)-4'-Desmethoxyepisilvestrol." Journal of the American Chemical Society 131.4 (2009): 1607-1616. Link to Full Text for this item Link to SFX for this item
7. Raza, F. "Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence." Biochemical Society transactions 43.6 (2015): 1227-1233. Link to SFX for this item
8. Callahan, K P P. "Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity." Leukemia 28.10 (2014): 1960-8. Link to Full Text for this item Link to SFX for this item
9. How, J. "The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics." Blood Cancer Journal (2013). Link to Full Text for this item Link to SFX for this item
10. Park, Yong S. "Suppression of IL-8 production in gastric epithelial cells by MUC1 mucin and peroxisome proliferator-associated receptor-γ." American journal of physiology: Gastrointestinal and liver physiology (2012): -74. Link to SFX for this item
11. Boris-Lawrie, K. "Multiple facets of junD gene expression are atypical among AP-1 family members." Oncogene 27.35 (2008): 4757-4767. Link to Full Text for this item Link to SFX for this item
12. Swamy, K. "Mitsunobu and Related Reactions: Advances and Applications." Chemical reviews 109.6 (2009): 2551-2651. Link to Full Text for this item Link to SFX for this item
13. Hou, Y. "Polymer Semiconductors for Artificial Photosynthesis: Hydrogen Evolution by Mesoporous Graphitic Carbon Nitride with Visible Light." Journal of the American Chemical Society 131.5 (2009): 1680-1681. Link to Full Text for this item Link to SFX for this item
14. Pickering, Becky M M. "The implications of structured 5′ untranslated regions on translation and disease." Seminars in cell & developmental biology 16.1 (2005): 39-47. Link to SFX for this item
15. Alibes, R. "Highly efficient and diastereoselective synthesis of (+)-lineatin." Organic letters 6.9 (2004): 1449-1452. Link to Full Text for this item Link to SFX for this item
16. Chu, H. "Regioselective hydroxylation of 2-hydroxychalcones by dimethyldioxirane towards polymethoxylated flavonoids." Tetrahedron 60.11 (2004): 2647-2655. Link to SFX for this item
17. Mello, R. "A simple protocol for the generation of methyl(trifluoromethyl)dioxirane." Synlett 2007.1 (2007): 47-50. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced